Hepatic insulin signaling modulates glucose output to maintain serum glucose hemostasis through activating insulin receptor substrate (IRS)-1/2/PI3K/Akt pathway [11]; this pathway impairment causes hyperglycemia and compensatory hyperinsulinemia, cooperatively preceding systemic insulin resistance. The gene discussed is INS; the disease is Hyperinsulinemia.